DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 201 filers reported holding DEPOMED INC in Q1 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 118 | -65.6% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 343 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 343 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -50.0% | 343 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | 0.0% | 343 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | -42.9% | 343 | -6.5% | 0.00% | – |
| Q4 2016 | $7,000 | -95.2% | 367 | -93.7% | 0.00% | -100.0% |
| Q3 2016 | $147,000 | +1030.8% | 5,869 | +817.0% | 0.01% | +700.0% |
| Q2 2016 | $13,000 | +85.7% | 640 | +64.5% | 0.00% | – |
| Q4 2015 | $7,000 | – | 389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
| Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
| Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
| Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
| Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
| Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
| Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
| Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
| HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
| OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |